COMMUNIQUÉS West-GlobeNewswire

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
08/01/2026
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
08/01/2026
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive preliminary results from [...]
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
08/01/2026
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market [...]
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
08/01/2026
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann [...]
Spyre Therapeutics Announces Grants of Inducement Awards
08/01/2026
WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to [...]
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
08/01/2026
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, [...]
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
08/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
08/01/2026
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), announces that the cumulative number of Proof of [...]
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
08/01/2026
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax [...]
Cellectis annonce sa stratégie et ses jalons attendus en 2026
08/01/2026
NEW YORK, 08 janv. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour [...]
Cellectis Announces 2026 Strategy and Catalysts
08/01/2026
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
08/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
08/01/2026
FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , a developer of innovative surgical robotic technologies dedicated to [...]
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
08/01/2026
Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you choose the best creatine for women. New York City,, Jan. 08, 2026 (GLOBE NEWSWIRE) -- In 2026 [...]
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
09/01/2026
Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company [...]
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
09/01/2026
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
08/01/2026
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : [...]
Valneva SE - Declaration of voting rights - December 2025
08/01/2026
VALNEVA Declaration of shares and voting rights December 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint Joseph [...]
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
08/01/2026
Scaling People Practices for High Performance MORRISVILLE, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Syneos Health, a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of [...]

Pages